Overdose Deaths Soared to 70,000 Deaths last Year, Yet FDA Approves New Painkiller that Is 1000 Times More Powerful than Morphine

Pixabay
image_pdfimage_print
The FDA approved a powerful new opioid painkiller called Dsuvia that’s 10 times stronger than fentanyl, the deadly synthetic opioid that’s been blamed for the record number of drug overdose deaths recorded in 2017, and 1,000 times more powerful than morphine.  The potential that the drug will be diverted and abused is likely.  The FDA ignored the objections of lawmakers and its own advisory committee in the process.  AcelRx, the manufacturer of Dsuvia, anticipates $1.1 billion in annual sales, and hopes to have its product in hospitals early next year.  Public health risks pale in comparison to the enormous profits that the company stands to reap from sales. 

Purdue Pharma and other pioneers of powerful opioid painkillers probably felt a twinge of regret on Friday when the FDA approved a powerful new opioid painkiller that’s 10 times stronger than fentanyl  – the deadly synthetic opioid that’s been blamed for the record number of drug overdose deaths recorded in 2017 – and 1,000 times more powerful than morphine, ignoring the objections of lawmakers and its own advisory committee in the process.

After all that trouble that purveyors of opioids like Purdue and the Sackler family went to in order to win approval –doctoring internal research and suborning doctors to convince the FDA to approve powerful painkillers like OxyContin despite wildly underestimating the drug’s abuse potential – the agency might very well have approved those drugs any way? And opioid makers might have been able to avoid some of the legal consequences stemming from this dishonesty, like the avalanche of lawsuits brought by state AGs.

What’s perhaps even more galling is that the FDA approved the drug after official data showed 2017 was the deadliest year for overdose deaths in US history, with more than 70,000 recorded drug-related fatalities, many of which were caused by powerful synthetic opioids like the main ingredient in Dsuvia, the brand name under which the new painkiller will be sold.

Dsuvia is a 3-millimeter tablet of sufentanil made by AcelRx. It’s a sublingual tablet intended to provide effective pain relief in patients for whom most oral painkillers aren’t effective. The FDA’s advisory committee voted 10-3 to recommend approval of the drug, a decision that was accepted by the FDA on Friday. The agency justified its decision by insisting that Dsuvia would be subject to “very tight” restrictions.

Read full article here…

 

Related Post

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary

Classifieds

For classified advertising rates and terms, click here. The appearance of ads on this site does not signify endorsement by the publisher. We do not attempt to verify the accuracy of statements made therein or vouch for the integrity of advertisers. However, we will investigate complaints from readers and remove any message we find to be misleading or that promotes anything fraudulent, illegal, or unethical.

1
Leave a Reply

avatar
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
0 Comment authors
Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
trackback
G. Griffin report today 11/5/18 – Nesaranews

[…] The FDA approved a powerful new opioid painkiller called Dsuvia that’s 10 times stronger than fentanyl, the deadly synthetic opioid that’s been blamed for the record number of drug overdose deaths recorded in 2017, and 1,000 times more powerful than morphine.  The potential that the drug will be diverted and abused is likely.  The FDA ignored the objections of lawmakers and its own advisory committee in the process.  AcelRx, the manufacturer of Dsuvia, anticipates $1.1 billion in annual sales, and hopes to have its product in hospitals early next year.  Public health risks pale in comparison to the enormous profits… Read more »